viron

a complex group of biologics botanicals; shown to be effective in the management of adult patients with HIV-1 and HIV-2; no further information available 4/97

Networked: 11 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Al-Ali, Amein K: 1 article (07/2020)
2.	Al-Muhanna, Fahad: 1 article (07/2020)
3.	Al-Rubaish, Abdullah: 1 article (07/2020)
4.	Alomar, Fadhel A: 1 article (07/2020)
5.	Bidasee, Keshore R: 1 article (07/2020)
6.	McMillan, JoEllyn: 1 article (07/2020)
7.	Singh, Jaipaul: 1 article (07/2020)
8.	Diarra, Lysa: 1 article (01/2017)
9.	Ho, Eric S: 1 article (01/2017)
10.	McCauley, Caroline S: 1 article (01/2017)

Related Diseases

1.	Infections 01/01/2015 - "Eighty-two consecutive patients presenting to our outpatient clinics as already-known or newly-diagnosed cases of chronic hepatitis C virus (HCV) infection, were entered into the study and randomized to three groups to receive escalating doses of Viron for 6 months. " 01/01/2017 - "For example, the viron of begomoviruses prevailing in America encapsulates two similar-sized circular DNA components and both are required for systemic infection of plants. " 09/01/1996 - "Using a herpes simplex virus-1 (HSV-1) vector system we packaged the CaBP gene, parvalbumin, or the marker gene, beta-galactosidase (beta-gal), correctly in viron particles, which were found upon infection to express mRNA specific to these vectors. "
2.	Chronic Hepatitis C 01/01/2015 - "Eighty-two consecutive patients presenting to our outpatient clinics as already-known or newly-diagnosed cases of chronic hepatitis C virus (HCV) infection, were entered into the study and randomized to three groups to receive escalating doses of Viron for 6 months. "
3.	Myocardial Infarction 01/01/2009 - "One such viral serpin, Serp-1 is now in clinical trial (conducted by VIRON Therapeutics, Inc.) for acute unstable coronary syndromes (unstable angina and small heart attacks), representing a 'first in class' therapeutic study. "
4.	Unstable Angina 01/01/2009 - "One such viral serpin, Serp-1 is now in clinical trial (conducted by VIRON Therapeutics, Inc.) for acute unstable coronary syndromes (unstable angina and small heart attacks), representing a 'first in class' therapeutic study. "
5.	Neoplasms (Cancer) 07/01/1981 - "Administration of infectious RadLV systemically into RL12-NP tumor-bearing animals converted these tumors to viron antigen expressors with levels in superinfected tumors equivalent to those found in RL12-Rad-induced tumors. " 08/01/1975 - "Viron antigens were not detected in these cell lines, and no virus was isolated when tumor extracts were inoculated in Vero cells."

Related Drugs and Biologics

1.	Serpins
2.	Antigens
3.	Testosterone Congeners
4.	Pertussis Toxin
5.	Messenger RNA (mRNA)
6.	Parvalbumins
7.	Mesterolone (Proviron)
8.	Membrane Proteins (Integral Membrane Proteins)
9.	Hemagglutinins (Hemagglutinin)
10.	Circular DNA

Related Therapies and Procedures

1.	Therapeutics